Reemergence of chloroquine (CQ) analogs as multi-targeting antimalarial agents: A review

European Journal of Medicinal Chemistry

Volumn 90, Issue , 2015, Pages 280-295

  Mushtaque, Md ^a   Shahjahan, ^a  

^a Al Falah School of Engineering and Technology   (India)

Author keywords

Chloroquine analogs; CQR CQS strains; Malaria; Mechanism of action

Indexed keywords

4 AMINOQUINOLINE; AMINOQUINOLINE DERIVATIVE; AZATADINE; CHLOROQUINE; CHLORPHENIRAMINE; CYPROHEPTADINE; IMIPRAMINE; KETOTIFEN; PROMETHAZINE; VERAPAMIL; ANTIMALARIAL AGENT;

ANTIMALARIAL ACTIVITY; ANTIMALARIAL DRUG RESISTANCE; CHEMICAL MODIFICATION; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; MALARIA; NONHUMAN; PHARMACOPHORE; PLASMODIUM FALCIPARUM; REVIEW; BIOLOGICAL ACTIVITY; DRUG EFFECT; DRUG TARGETING; IC50; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; HUMANS; MALARIA;

EID: 84920872473     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: None     Document Type: Review

References (116)

1. A.L. Demain, S. Sanchez, Microbial drug discovery: 80 years of progress, J. Antibiot. 62 (2009) 5e16
2. Tropical Diseases, http://www.astmh.org/Content/NavigationMenu/Education/Tropical Medicine QA/Major-Tropical-Disea.htm (last accessed 22.05.14
3. World Malaria Report, 2013
4. A.V. Pandey, H. Bisht, V.K. Babbarwal, J. Srivastava, K.C. Pandey, V.S. Chauhan, Mechanism of malarial haem detoxification inhibition by chloroquine, Biochem. J. 355 (2001) 333-338
5. J.F. Trape, A. Tall, C. Sokhna, A.B. Ly, N. Diagne, O. Ndiath, C. Mazenot, V. Richard, A. Badiane, F. Dieye-Ba, J. Faye, G. Ndiaye, F.D. Sarr, C. Roucher, C. Bouganali, H. Basséne, A. Touré-Baldé, C. Roussilhon, R. Perraut, A. Spiegel, J.L. Sarthou, L.P. da Silva, O.M. Puijalon, P. Druilhe, C. Rogier, The rise and fall of malaria in a west African rural community, Dielmo, Senegal, from 1990 to 2012: a 22 year longitudinal study, Lancet Infect. Dis. 14 (2014) 476-488
6. J.F. Trape, G. Pison, M.P. Preziosi, C. Enel, A. Desgrées du Loû, V. Delaunay, B. Samb, E. Lagarde, J.F. Molez, F. Simondon, Impact of chloroquine resistance on malaria mortality, CR Acad. Sci. Paris 321 (1998) 689-697
7. M. Ballif, J. Hii, J. Marfurt, A. Crameri, A. Fafale, I. Felger, H.P. Beck, B. Genton, Monitoring of malaria parasite resistance to chloroquine and sulphadoxinepyrimethamine in the Solomon Islands by DNA microarray technology, Malar. J. 9 (2010) 270
8. T.E. Wellems, C.V. Plowe, Chloroquine-resistant malaria, J. Infect. Dis. 184 (2001) 770-776
9. U. Farooq, R.C. Mahajan, Drug resistance in malaria, J. Vect. Borne Dis. 41 (2004) 45-53
10. C. Bonsch, C. Kempf, I. Mueller, L. Manning, M. Laman, T.M. Davis, C. Ros, Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication, PLoS Negl. Trop. Dis. 4 (2010) e669
11. A.K. Lukens, L.S. Ross, R. Heidebrecht, F.J. Gamo, M.J. Lafuente-Monasterio, M.L. Booker, D.L. Hartl, R.C. Wiegand, D.F. Wirth, Harnessing evolutionary fitness in Plasmodium falciparum for drug discovery and suppressing resistance, Proc. Natl. Acad. Sci. U. S. A. 111 (2014) 799-804
12. S.K. Martin, A.M. Oduola, W.K. Milhous, Reversal of chloroquine resistance in Plasmodium falciparum by verapamil, Science 235 (1987) 899-901
13. B. Witkowski, C. Amaratunga, N. Khim, S. Sreng, P. Chim, Saorin Kim, P. Lim, S. Mao, C. Sopha, B. Sam, J.M. Anderson, D. Socheat, C.M. Chuor, W.R.J. Taylor, S. Seila, O. Mercereau-Puijalon, R.M. Fairhurst, D. Menard, Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies, Lancet Infect. Dis. 13 (2013) 1043-1049
14. K.J. Palmer, S.M. Holliday, R.N. Brogden, Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy, Drugs 45 (1993) 430-475
15. V.K. Zishiri, R. Hunter, P.J. Smith, D. Taylor, R. Summers, K. Kirk, R.E. Martin, T.J. Egan, A series of structurally simple chloroquine chemosensitizing dibemethin derivatives that inhibit chloroquine transport by PfCRT, Eur. J. Med. Chem. 46 (2011) 1729-1742
16. L.J. Bruce-Chwatt (Ed.), Chemotherapy of Malaria, second ed.WHO Monograph Series, vol. 27, World Health Organization, Geneva, 1981
17. Chloroquine, http://www.drugbank.ca/drugs/DB00608#identification (last accessed 22.05.14
18. S. Salomone, T. Godfraind, Drugs that reverse chloroquine resistance in malaria, Trends Pharmacol. Sci. 11 (1990) 475-476
19. E. Veignie, S. Moreau, The mode of action of chloroquine non-weak base properties of 4-aminoquinolines and antimalarial effects on strains of Plasmodium, Ann. Trop. Med. Parasitol. 85 (1991) 229-237
20. P.J. De Vries, B. Oosterhuis, C.J. Van Boxtel, Single-dose pharmacokinetics of chloroquine and its main metabolite in healthy volunteers, Drug Invest. 8 (1994) 143-149
21. J.C.F.M. Wetsteyn, P.J. De Vries, B. Oosterhuis, C.J. Van Boxtel, The pharmacokinetics of three multiple dose regimens of chloroquine: implications for malaria chemoprophylaxis, Br. J. Clin. Pharmacol. 39 (1995) 696-699
22. Annual Report, 2011-2012, http://pharmaceuticals.gov.in/annualreport2012.pdf (last accessed 22.05.14
23. Chloroquine for Malaria, http://www.webmd.com/a-to-z-guides/chloroquine-for-malaria (last accessed 22.05.14
24. Communicable Diseases, Annual Report 2012-13. Indian Council of Medical Research, http://www.icmr.nic.in/annual/2012-13/english/3.pdf (last accessed 22.05.14
25. Choroquine Phosphate Oral, http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682318.html (last accessed 22.05.14
26. H.M. Staines, S. Krishna, Treatment and Prevention of Malaria: Antimalarial Drug Chemistry, Action and Use, Springer, Basel, 2012
27. S. Krishna, N.J. White, Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications, Clin. Pharmacokinet. 30 (1996) 263-299
28. C.A. Homewood, D.C. Warhurst, W. Peters, V.C. Baggaley, Lysosomes, pH and the anti-malarial action of chloroquine, Nature 235 (1972) 50-52
29. D.J. Sullivan Jr., I.Y. Gluzman, D.G. Russell, D.E. Goldberg, On the molecular mechanism of chloroquine's antimalarial action, Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 11865-11870
30. T.J. Egan, Recent advances in understanding the mechanism of hemozoin (malaria pigment) formation, J. Inorg. Biochem. 102 (2008) 1288-1299
31. D.E. Goldberg, A.F.G. Slater, A. Cerami, G.B. Henderson, Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 2931-2935
32. J.A. Shelnutt, Metal effects on metalloporphyrins and on their pep chargetransfer complexes with aromatic acceptors: Urohemin complexes, Inorg. Chem. 22 (1983) 2535-2544
33. N.J. White, Aggregation of porphyrins and metalloporphyrins, in: Dolphin (Ed.), The Porphyrins, Academic Press, New York, 1978, pp. 303-339
34. E. Hempelmann, Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors, Parasitol. Res. 100 (2007) 671-676
35. M. Chinappi, A. Via, P. Marcatili, A. Tramontano, On the mechanism of chloroquine resistance in Plasmodium falciparum, PLoS One 5 (2010) e14064
36. C.H. Kaschula, T.J. Egan, R. Hunter, N. Basilico, S. Parapini, D. Taramelli, E. Pasini, D. Monti, Structureeactivity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position, J. Med. Chem. 45 (2002) 3531-3539
37. S. Nsumiwa, D. Kuter, S. Wittlin, K. Chibale, T.J. Egan, Structureeactivity relationships for ferriprotoporphyrin IX association and b-hematin inhibition by 4-aminoquinolines using experimental and ab initio methods, Bioorg. Med. Chem. 21 (2013) 3738-3748
38. T.J. Egan, R. Hunter, C.H. Kaschula, H.M. Marques, A. Misplon, J.C. Walden, Structureefunction relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of bhematin formation, and antiplasmodial activity, J. Med. Chem. 43 (2000) 283-291
39. S. Ray, P.B. Madrid, P. Catz, S.E. Le Valley, M.J. Furniss, L.L. Rausch, R.K. Guy, J.L. De Risi, L.V. Iyer, C.E. Green, J.C. Mirsalis, Development of a new generation of 4-aminoquinoline antimalarial compounds using predictive pharmacokinetic and toxicology models, J. Med. Chem. 53 (2010) 3685-3695
40. Treatment of Malaria, http://www.globalmalariafoundation.com/Malaria%Treatment.html (last accessed 22.05.14
41. S. Pou, R.W. Winter, A. Nilsen, J.X. Kelly, Y. Li, J.S. Doggett, E.W. Riscoe, K.W. Wegmann, D.J. Hinrichs, M.K. Riscoe, Sontochin as a guide to the development of drugs against chloroquine-resistant malaria, Antimicrob. Agents Chemother. 56 (2012) 3475-3480
42. M. Henry, S. Briolant, A. Fontaine, J. Mosnier, E. Baret, R. Amalvict, T. Fusaï, L. Fraisse, C. Rogier, B. Pradines, In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum, Antimicrob. Agents Chemother. 52 (2008) 2755-2759
43. S.J. Burgess, A. Selzer, J.X. Kelly, M.J. Smilkstein, M.K. Riscoe, D.H. Peyton, A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum, J. Med. Chem. 49 (2006) 5623-5625
44. S. Andrews, S.J. Burgess, D. Skaalrud, J.X. Kelly, D.H. Peyton, Reversal agent and linker variants of reversed chloroquines: activities against Plasmodium falciparum, J. Med. Chem. 53 (2010) 916-919
45. S.J. Burgess, J.X. Kelly, S. Shomloo, S. Wittlin, R. Brun, K. Liebmann, D.H. Peyton, Synthesis, structureeactivity relationship, and mode-of-action studies of antimalarial reversed chloroquine compounds, J. Med. Chem. 53 (2010) 6477-6489
46. P.F. Salas, C. Herrmann, J.F. Cawthray, C. Nimphius, A. Kenkel, J. Chen, C. De Kock, P.J. Smith, B.O. Patrick, M.J. Adam, C. Orvig, Structural characteristics of chloroquine-bridged ferrocenophane analogues of ferroquine may obviate malaria drug-resistance mechanisms, J. Med. Chem. 56 (2013) 1596-1613
47. C. Rusconi, N. Vaiana, M. Casagrande, N. Basilico, S. Parapini, D. Taramelli, S. Romeo, S. Paratore, Synthesis and comparison of antiplasmodial activity of (+), (-) and racemic 7-chloro-4-(N-lupinyl)aminoquinoline, Bioorg. Med. Chem. 20 (2012) 5980-5985
48. N.I. Wenzel, N. Chavain, Y. Wang, W. Friebolin, L. Maes, B. Pradines, M. Lanzer, V. Yardley, R. Brun, C. Herold-Mende, C. Biot, K. Tóth, E. Davioud- Charvet, Antimalarial versus cytotoxic properties of dual drugs derived from 4-aminoquinolines and Mannich bases: interaction with DNA, J. Med. Chem. 53 (2010) 3214-3226
49. Ruthenium Compounds as Anticancer Agents, http://www.rsc.org/images/Anticancer%20DrugséiC-January2012-tcm18-212416.pdf (last accessed 22.05.14
50. K.H. Maclean, F.C. Dorsey, J.L. Cleveland, M.B. Kastan, Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis, J. Clin. Invest. (2008) 11879-11888
51. C.V. Dang, Antimalarial therapy prevents Myc-induced lymphoma, J. Clin. Invest. 118 (2008) 15-17
52. M.B. Kastan, C.J. Bakkenist. Prophylactic treatment of cancer with chloroquine compounds, U.S. Patent Appl. Publ. 20050032834, February 10, 2005
53. World Malaria Report, World Health Organization, 2008. http://www.who. int/malaria/wmr2008/(last accessed 22.05.14
54. J. Sachs, P. Malaney, The economic and social burden of malaria, Nature 415 (2002) 680-685
55. S. Croft, Antimalarial chemotherapy: mechanisms of action, resistance and new directions in drug discovery, Drug Discov. Today 6 (2001) 1151
56. C. Herrmann, P.F. Salas, B.O. Patrick, C. De Kock, P.J. Smith, M.J. Adam, C. Orvig, 1,2- disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarial agents, Dalton Trans. 41 (2012) 6431-6442
57. C. Herrmann, P.F. Salas, B.O. Patrick, C. De Kock, P.J. Smith, M.J. Adam, C. Orvig, Modular synthesis of 1,2- and 1,10-disubstituted ferrocenyl carbohydrate chloroquine and mefloquine conjugates as potential antimalarial agents, Organometallics 31 (2012) 5748-5759
58. C. Biot, W. Daher, C.M. Ndiaye, P. Melnyk, B. Pradines, N. Chavain, A. Pellet, L. Fraisse, L. Pelinski, C. Jarry, J. Brocard, J. Khalife, I. Forfar-Bares, D. Dive, Probing the role of the covalent linkage of ferrocene into a chloroquine template, J. Med. Chem. 49 (2006) 4707-4714
59. S. Gemma, G. Campiani, S. Butini, B.P. Joshi, G. Kukreja, S.S. Coccone, M. Bernetti, M. Persico, V. Nacci, I. Fiorini, E. Novellino, D. Taramelli, N. Basilico, S. Parapini, V. Yardley, S. Croft, S. Keller-Maerki, M. Rottmann, R. Brun, M. Coletta, S. Marini, G. Guiso, S. Caccia, C. Fattorusso, Combining 4- aminoquinoline- and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarials, J. Med. Chem. 52 (2009) 502-513
60. S. Gemma, C. Camodeca, Sanna S. Coccone, B.P. Joshi, M. Bernetti, V. Moretti, S. Brogi Bonache, M.C. De Marcos, L. Savini, D. Taramelli, N. Basilico, S. Parapini, M. Rottmann, R. Brun, S. Lamponi, S. Caccia, G. Guiso, R.L. Summers, R.E. Martin, S. Saponara, B. Gorelli, E. Novellino, G. Campiani, S. Butini, Optimization of 4- aminoquinoline/clotrimazole-based hybrid antimalarials: further structure-activity relationships, in vivo studies, and preliminary toxicity profiling, J. Med. Chem. 55 (2012) 6948-6967
61. S. Howard, V. Berdini, J.A. Boulstridge, M.G. Carr, D.M. Cross, J. Curry, L.A. Devine, T.R. Early, L. Fazal, A.L. Gill, M. Heathcote, S. Maman, J.A. Matthews, R.L. Mc-Menamin, E.F. Navarro, M.A. O'Brien, M. O'Reilly, D.C. Rees, M. Reule, D. Tisi, G. Williams, M. Vinkovic, P.G. Wyatt, Fragmentbased discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity, J. Med. Chem. 52 (2009) 379-388
62. A.A. Bekhit, T. Abdel-Aziem, Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents, Bioorg. Med. Chem. 12 (2004) 1935-1945
63. S. Manohar, U.C. Rajesh, S.I. Khan, B.L. Tekwani, D.S. Rawat, Novel 4- aminoquinoline-pyrimidine based hybrids with improved in vitro and in vivo antimalarial activity, ACS Med. Chem. Lett. 3 (2012) 555-559
64. S. Pandey, P. Agarwal, K. Srivastava, S. Rajakumar, S.K. Puri, P. Verma, J.K. Saxena, A. Sharma, J. Lal, P.M. Chauhan, Synthesis and bioevaluation of novel 4-aminoquinoline- tetrazole derivatives as potent antimalarial agents, Eur. J. Med. Chem. 66 (2013) 69-81
65. M. Casagrande, A. Barteselli, N. Basilico, S. Parapini, D. Taramelli, A. Sparatore, Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7- chloro-4 aminoquinoline, Bioorg. Med. Chem. 20 (2012) 5965-5979
66. K. Singh, H. Kaur, P. Smith, C. De Kock, K. Chibale, J. Balzarini, Quinolinepyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies, J. Med. Chem. 57 (2014) 435-448
67. J.K. Natarajan, J.N. Alumasa, K. Yearick, K.A. Ekoue-Kovi, L.B. Casabianca, A.C. De Dios, C. Wolf, P.D. Roepe, 4-N-, 4-S-, and 4-O-chloroquine analogues: influence of side chain length and quinolyl nitrogen pKa on activity vs chloroquine resistant malaria, J. Med. Chem. 51 (2008) 3466-4347
68. M. Sharma, K. Chauhan, S.S. Chauhan, A. Kumar, S.V. Singh, J.K. Saxena, P. Agarwal, K. Srivastava, S.R. Kumar, S.K. Puri, P. Shah, M.I. Siddiqi, P.M.S. Chauhan, Synthesis of hybrid 4-anilinoquinoline triazines as potent antimalarial agents, their in silico modeling and bioevaluation as Plasmodium falciparum transketolase and b-hematin inhibitors, Med. Chem. Commun. 3 (2012) 71-79
69. C.G. Nevill, F.H. Verhoeff, C.G. Munafu, W.R. Tenhove, H.J. Van Der Kaay, J.B.O. Were, A comparison of amodiaquine and chloroquine in the treatment therapy of falciparum malaria in Kenya, East Afr. Med. J. 71 (1994) 167-170
70. O. Muller, M.B. Vanhensbroek, S. Jaffer, C. Drakeley, C. Okorie, D. Joof, M. Pinder, B.A. Greenwood, Randomised trial of chloroquine, amodiaquine and pyrimethamine-sulfadoxine in Gambian children with uncomplicated malaria, Trop. Med. Int. Health 1 (1996) 124-132
71. S. Manohar, S.I. Khan, D.S. Rawat, Synthesis, antimalarial activity and cytotoxicity of 4-aminoquinoline-triazine conjugates, Bioorg. Med. Chem. Lett. 20 (2010) 322-325
72. S. Manohar, S.I. Khan, D.S. Rawat, Synthesis of 4-aminoquinoline-1,2,3- triazole and 4-aminoquinoline-1,2,3-triazole-1,3,5-triazine hybrids as potential antimalarial agents, Chem. Biol. Drug Des. 78 (2011) 124-136
73. S. Manohar, S.I. Khan, D.S. Rawat, 4-aminoquinoline-triazinebased hybrids with improved in vitro antimalarial activity against CQ-sensitive and CQresistant strains of Plasmodium falciparum, Chem. Biol. Drug Des. 81 (2010) 625-630
74. D.S. Rawat, S. Manohar, U.C. Rajesh, D. Kumar, A. Thakur, M. Tripathi, P.L. Reddy, S.K. Kandi, S. Vardhineni, K.-S. Kim, C.-H. Kim. Aminoquinoline derivatives and uses thereof, WO2013134047 A2
75. B. Singh, D. Chetia, S.K. Puri, Synthesis and in vitro and in vivo antimalarial activity of novel 4-anilinoquinoline Mannich base derivatives, Med. Chem. Res. 20 (2011) 1523-1529
76. P.M. O'Neill, B.K. Park, A.E. Shone, J.L. Maggs, P. Roberts, P.A. Stocks, G.A. Biagini, P.G. Bray, P. Gibbons, N. Berry, P.A. Winstanley, A. Mukhtar, R. Bonar-Law, S. Hindley, R.B. Bambal, C.B. Davis, M. Bates, T.K. Hart, S.L. Gresham, R.M. Lawrence, R.A. Brigandi, F.M. Gomez-delas-Heras, D.V. Gargallo, S.A. Ward, Candidate selection and preclinical evaluation of Ntert- butyl isoquine (GSK369796), an affordable and effective 4- aminoquinoline antimalarial for the 21st century, J. Med. Chem. 52 (2009) 1408-1415
77. D. Cornut, H. Lemoine, O. Kanishchev, E. Okada, F. Albrieux, A.H. Beavogui, A.- L. Bienvenu, S. Picot, J.-P. Bouillon, M. Médebielle, Incorporation of a 3-(2,2,2- Trifluoroethyl)-g-hydroxy-g-lactam motif in the side chain of 4- aminoquinolines syntheses and antimalarial activities, J. Med. Chem. 56 (2013) 73-83
78. P.G. Bray, R.E. Martin, L. Tilley, S.A. Ward, K. Kirk, D.A. Fidock, Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance, Mol. Microbiol. 56 (2005) 323-333
79. D.A. Fidock, T. Nomura, A.K. Talley, R.A. Cooper, S.M. Dzekunov, M.T. Ferdig, L.M. Ursos, A.B. Sidhu, B. Naude, K.W. Deitsch, X.Z. Su, J.C. Wootton, P.D. Roepe, T.E. Wellems, Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance, Mol. Cell. 6 (2000) 861-871
80. D.J. Krogstad, I.Y. Gluzman, D.E. Kyle, A.M. Oduola, S.K. Martin, W.K. Milhous, P.H. Schlesinger, Efflux of chloroquine from Plasmodium falciparum: mechanism b of chloroquine resistance, Science 238 (1987) 1283-1285
81. K.V. Sashidhara, S.R. Avula, G.R. Palnati, S.V. Singh, K. Srivastava, S.K. Puri, J.K. Saxena, Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum, Bioorg. Med. Chem. Lett. 22 (2012) 5455-5459
82. F.A.R. Ruiz, R.N. García-Sánchez, S.V. Estupiñan, A. Gómez-Barrio, D.F.T. Amado, B.M. Pérez-Solórzano, J.J. Nogal-Ruiz, A.R. Martínez-Fernández, V.V. Kouznetsov, Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds, Bioorg. Med. Chem. 19 (2011) 4562-4573
83. R. Hunter, T.J. Egan, V.K. Zishiri. Generic Quinoline Compounds Containing a Dibemethin Group, WO2010018555A2, Feb 18, 2010
84. V.K. Zishiri, M.C. Joshi, R. Hunter, K. Chibale, P.J. Smith, R.L. Summers, R.E. Martin, T.J. Egan, Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT), J. Med. Chem. 54 (2011) 6956-6968
85. D.H. Peyton, S. Burgess. Quinoline derivatives and uses thereof. US Patent 7968539 B2, 28 June 2011
86. M. Delves, D. Plouffe, C. Scheurer, S. Meister, S. Wittlin, E.A. Winzeler, R.E. Sinden, D. Leroy, The activities of current antimalarial drugs on the life cycle stages of plasmodium: a comparative study with human and rodent parasites, PLoS Med. 9 (2012) e1001169
87. E.R. Derbyshire, M.M. Mota, J. Clardy, The next opportunity in anti-malaria drug discovery: the liver stage, PLoS Pathog. 7 (2011) e1002178
88. B.C. Pérez, C. Teixeira, I.S. Albuquerque, J. Gut, P.J. Rosenthal, J.R.B. Gomes, M. Prudencio, P. Gomes, N-cinnamoylated chloroquine analogues as dualstage antimalarial leads, J. Med. Chem. 56 (2013) 556-567
89. B.C. Pérez, C. Teixeira, J. Gut, P.J. Rosenthal, J.R.B. Gomes, P. Gomes, Cinnamic acid/chloroquinoline conjugates as potent agents against chloroquineresistant Plasmodium falciparum, Chem. Med. Chem. 7 (2012) 1537-1540
90. M. Lodige, M.D. Lewis, E.S. Paulsen, H.L. Esch, G. Pradel, L. Lehmann, R. Brun, G. Bringmann, A.-K. Mueller, A primaquine-chloroquine hybrid with dual activity against plasmodium liver and blood stages, Inter. J. Med. Microbiol. 303 (2013) 539-547
91. E. Beutler, Drug-induced hemolytic anemia, Pharmacol. Rev. 1 (1969) 73-103
92. C.R. Menéndez, L.D. Pérez, S.C. Luzardo, Hemolysis and primaquine treatment. Preliminary report, Rev. Cuba. Med. Trop. 49 (1997) 136-138
93. F.J. Pinto, S.A. Piramal, R. Pratap, P. Bhaduri, P. Thapliyal, K. Puri, P. Dutta, K. Dwivedi, S. Singh, P. Srivastava, V.C. Pandey, S. Shrivastava, S.K. Singh, R.C. Gupta, J.S. Shrivastava, O.P. Asthana. Combination kit used in the treatment of malaria US 7404962 B1,US patent 7404962B1, July 29 2008
94. F.E. Sáenz, T. Mutka, K. Udenze, A.M.J. Oduola, D.E. Kyle, Novel 4- aminoquinoline analogs highly active against the blood and sexual stages of plasmodium in vivo and in vitro, Antimicrob. Agents Chemother. 56 (2012) 4685-4692
95. L.M. Alcantara, J. Kim, C.B. Moraes, C.H. Franco, K.D. Franzoi, S. Lee, L.H. Freitas-Junior, L.S. Ayong, Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites, Exp. Parasitol. 134 (2013) 235-243
96. J. Savulescu, Thalassaemia major: the murky story of deferiprone, BMJ 328 (2004) 358-359
97. S.S. Gehrke, E.G. Pinto, D. Steverding, K. Pleban, A.G. Tempone, R.C. Hider, G.K. Wagner, Conjugation to 4-aminoquinoline improves the antitrypanosomal activity of Deferiprone-type iron chelator, Bioorg. Med. Chem. 21 (2013) 805-813
98. W.A. Cortopassi, A.A. Oliveira, A.P. Guimarães, M.N. Rennó, A.U. Krettli, Tanos C.C. França, Docking studies on the binding of quinoline derivatives and hematin to plasmodium falciparum lactate dehydrogenase, J. Biomol. Struct. Dyn. 29 (2011) 207-218
99. F.A. Rojas, V.V. Kouznetsov, Property-based design and synthesis of new chloroquine hybrids via simple incorporation of 2-imino-thiazolidin-4-one or 1H-pyrrol-2,5-dione fragments on the 4-amino-7-chloroquinoline side chain, J. Braz. Chem. Soc. 22 (2011) 1774-1781
100. D. De, F.M. Krogstad, F.B. Cogswell, D.J. Krogstad, Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro, Am. J. Trop. Med. Hyg. 55 (1996) 579-583
101. R.G. Ridley, W. Hfheinz, H. Matile, C. Jaquet, A. Dorn, R. Masciadri, S. Jolidon, W.F. Richter, A. Guenzi, M.A. Girometta, H. Urwyler, Huber, S. Thaithong, W. Peters, 4-Aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum, Antimicrob. Agents Chemother. 40 (1996) 1846-1854
102. A.C.C. Aguiar, R.D.M. Santos, F.J.B. Figueiredo, W.A. Cortopassi, A.S. Pimentel, T.C.C. França, M.R. Meneghetti, A.U. Krettli, Antimalarial activity and mechanisms of action of two novel 4-aminoquinolines against chloroquineresistant parasites, PLoS One 7 (2012) e37259
103. S.R. Vippagunta, A. Dorn, H. Matile, A.K. Bhattacharjee, J.M. Karle, W.Y. Ellis, R.G. Ridley, J.L. Vennerstrom, Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth, J. Med. Chem. 42 (1999) 4630-4639
104. K.K. Raj, S. Manohar, V.R. Talluri, D.S. Rawat, Insights into activity enhancement of 4-aminoquinoline-based hybrids using atom-based and field-based QSAR studies, Med. Chem. Res. (2014), http://dx.doi.org/10.1007/s00044-014-1195-6
105. F. Kobarfard, V. Yardley, S. Little, F. Daryaee, K. Chibale, Synthesis of aminoquinoline-based aminoalcohols and oxazolidinones and their antiplasmodial activity, Chem. Biol. Drug Des. 79 (2012) 326-331
106. M. Idenovi, D.M. Opsenica, J.C. Burnett, L. Gomba, J.E. Nuss, Z. Selakovi, J. Konstantinovi, M. Krsti, S. Segan, M. Zlatovi, R.J. Sciotti, S. Bavari, B.A. Solaja, Second generation steroidal 4-aminoquinolines are potent, dual-target inhibitors of the Botulinum neurotoxin serotype A metalloprotease and P. falciparum Malaria, J. Med. Chem. 57 (2014) 4134-4153
107. J.C. Burnett, D. Opsenica, K. Sriraghavan, R.G. Panchal, G. Ruthel, A.R. Hermone, T.L. Nguyen, T.A. Kenny, D.J. Lane, C.F. McGrath, J.J. Schmidt, J.L. Vennerstrom, R. Gussio, B.A. Solaja, S. Bavari, A refined pharmacophore identifies potent 4- amino-7-chloroquinoline-based inhibitors of the Botulinum neurotoxin serotype A metalloprotease, J. Med. Chem. 50 (2007) 2127-2136
108. B.A. Solaja, D. Opsenica, K.S. Smith, W.K. Milhous, N. Terzi, I. Opsenica, J.C. Burnett, J. Nuss, R. Gussio, S. Bavari, Novel 4-aminoquinolines active against chloroquine-resistant and sensitive P. falciparum strains that also inhibit Botulinum serotype A, J. Med. Chem. 51 (2008) 4388-4391
109. M.J. Clarke, Oncological implications of the chemistry of ruthenium, in: H. Sigel (Ed.), Metal Ions in Biological Systems, Metal Complexes as Anticancer Agents, vol. 11, Marcel Dekker, Basel and New York, 1980, p. 231
110. C.S. Rajapakse, A. Martínez, B. Naoulou, A.A. Jarzecki, L. Suárez, C.n Deregnaucourt, V. Sinou, J. Schrével, E. Musi, G. Ambrosini, G.K. Schwartz, R.A. Sánchez-Delgado, Synthesis, characterization, and in vitro antimalarial and antitumor activity of new ruthenium(II) complexes of chloroquine, Inorg. Chem. 48 (2009) 1122-1131
111. M. Navarro, H. Pérez, R.A. Sánchez-Delgado, Toward a novel metal-based chemotherapy against tropical diseases. 3. Synthesis and antimalarial activity in vitro and in vivo of the new gold-chloroquine complex [Au(PPh3)(CQ)]PF6, J. Med. Chem. 40 (1997) 1937-1939
112. Y. Li, C. De Kock, P.J. Smith, H. Guzgay, D.T. Hendricks, K. Naran, V. Mizrahi, D.F. Warner, K. Chibale, G.S. Smith, Synthesis, characterization, and pharmacological evaluation of silicon-containing aminoquinoline organometallic complexes as antiplasmodial, antitumor, and antimycobacterial agents, Organometallics 32 (2013) 141-150
113. K. Goyal, H. Kaur, R. Sehgal, Low-dose primaquine for falciparum malaria, Lancet Infect. Dis. 14 (2014) 449
114. A. Savarino. Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors. US patent 7553844B2, Jun 30, 2009
115. A. Savarino, L. Gennero, H.C. Chen, D. Serrano, F. Malavasi, J.R. Boelaert, K. Sperber, Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity, AIDS 15 (2001) 2221-2229
116. A. Savarino, L. Gennero, K. Sperber, J.R. Boelaert, The anti-HIV-1 activity of chloroquine, J. Clin. Virol. 20 (2001) 131-135